2015
DOI: 10.1134/s0003683815060150
|View full text |Cite
|
Sign up to set email alerts
|

Enzymatic synthesis of β-lactam acids (review)

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
5
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 17 publications
(5 citation statements)
references
References 56 publications
0
5
0
Order By: Relevance
“…Glycoside hydrolases (Adlercreutz, 2017;Seibel et al, 2006;Vera et al, 2020;Zeuner, Jers, Mikkelsen, & Meyer, 2014), lipases (Adlercreutz, 2017;Subileau et al, 2017), amidases (Bruggink, Roos, & de Vroom, 1998;Giordano et al, 2006;Gololobov et al, 1990;Sio & Quax, 2004;Sklyarenko, El'darov, Kurochkina, & Yarotsky, 2015), and phosphatases (Ishikawa et al, 2002;Tasnádi, Staśko, Ditrich, Hall, & Faber, 2020; are industrial enzymes used in these synthetic processes. Mechanistically, the enzymatic reactions proceed in two catalytic steps via a covalent enzyme intermediate (Gololobov, Borisov, Belikov, & Švedas, 1988;Kasche, 1986;Marsden et al, 2020;Seibel et al, 2006;Zeuner et al, 2014).…”
Section: Introductionmentioning
confidence: 99%
“…Glycoside hydrolases (Adlercreutz, 2017;Seibel et al, 2006;Vera et al, 2020;Zeuner, Jers, Mikkelsen, & Meyer, 2014), lipases (Adlercreutz, 2017;Subileau et al, 2017), amidases (Bruggink, Roos, & de Vroom, 1998;Giordano et al, 2006;Gololobov et al, 1990;Sio & Quax, 2004;Sklyarenko, El'darov, Kurochkina, & Yarotsky, 2015), and phosphatases (Ishikawa et al, 2002;Tasnádi, Staśko, Ditrich, Hall, & Faber, 2020; are industrial enzymes used in these synthetic processes. Mechanistically, the enzymatic reactions proceed in two catalytic steps via a covalent enzyme intermediate (Gololobov, Borisov, Belikov, & Švedas, 1988;Kasche, 1986;Marsden et al, 2020;Seibel et al, 2006;Zeuner et al, 2014).…”
Section: Introductionmentioning
confidence: 99%
“…Over the past three decades, the chemical technology involved in producing antibiotics of the β-lactam class has progressively been replaced by biocatalyst technology which is cheaper and tends to be safer because of minimal side effects (A. . This shift is attributed to several factors contributing to the significant growth and development of biocatalysts are related to (1) the high quality of the final product; (2) the undeniable ecological benefits of biocatalysts such as mild reaction conditions (pH, temperature), excluding toxic reagents and providing increased product/waste ratios (decreased organic solvents and reagents); (3) increase in economic efficiency and competitiveness of enzymatic technology due to the improvement of each aspect (strain, biocatalyst, enzymatic transformation), as well as due to optimal process integration in the application of the one pot process (Alemzadeh et al, 2010;Sklyarenko et al, 2015). The current focus in the production of β-lactam antibiotics includes the synthesis of ampicillin, amoxicillin, cephalexin, cefachlor, and cefazolin.…”
Section: Role Of Pga Enzyme In Antibiotic Productionmentioning
confidence: 99%
“…Synthesis under kinetic control (KCS) involves a complex strategy. Conditions in KCS for β-lactam antibiotic synthesis have been optimized across various parameters such as pH (Sawant et al, 2020b), ionic strength (D. Yang et al, 2016), temperature (Sklyarenko et al, 2015), molar ratio of acyl donors and nucleophiles (Dai et al, 2001;Deng et al, 2015), and the composition of the medium with organic cosolvent (Deng et al, 2016), all aimed at enhancing the synthesis/hydrolysis ratio (S/H). This optimization has shown success in the synthesis of cephalologlysin in methanol, as well as ampicillin and cephalexin in glycol (Zhu & Cao, 2014).…”
Section: Role Of Pga Enzyme In Antibiotic Productionmentioning
confidence: 99%
“…Numerous enzymes successfully catalyzed the transformation of some compounds into pharmacological species, this category including antibiotics [136], analgesics [137], and some anti-inflammatory drugs [138]. An example is presented by Gilani and collaborators, who studied the production of (S)-naproxen under the action of three biocatalysts: CHI/lipase composite microparticles, CHI/lipase microparticles cross-linked with GA, and microparticles obtained by lipase immobilization in a commercial resin of Amberlite XAD7 type [138].…”
Section: Biomedical Applicationsmentioning
confidence: 99%